Literature DB >> 1244793

Letter: Trimethoprim-sulfamethoxazole and bacterial meningitis.

Z Farid, N I Girgis, W Yassin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1244793     DOI： 10.7326/0003-4819-84-1-50

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

2.  In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.

Authors:  D L Winslow; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

3.  In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  L P Elwell; H R Wilson; V B Knick; B R Keith
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

5.  Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.

Authors:  J M Mylotte; T R Bates; K A Sergeant; R E Matson; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.